News
Zacks.com on MSN1mon
Here's Why you Should Retain Nevro Stock in Your Portfolio Nowminimized bone removal and increased fusion potential compared to a posterolateral cylindrical-threaded single-implant system ...
Hosted on MSN2mon
Globus Medical strengthens SCS market position with $250m Nevro dealFollowing strong financial results revealed last month, US-headquartered Globus Medical has agreed to acquire spinal cord stimulation (SCS) company Nevro for $250m to reinforce its position in the ...
Nevro’s comprehensive HFX spinal cord stimulation (SCS) platform includes the Senza ... enabling technologies and future implant solutions. Furthermore, the company’s scale and operational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback